UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 16, 2021
Accession Number:
Submission Type:
CIK:
0001841330
Company Name:
Pasithea Therapeutics Corp.
File Number:
333-261573